InSnip Pure Signal, No Noise
✓ Source-backedMoney & Work
US biodefence budget puts ASX biotechs on alert
The US strategy names US$66.9 billion in five-year biodefence spending, with several ASX biotechs already tied to US agencies.
Why it mattersIt flags where new government money may flow, which matters for biotech contracts and valuations.
Free. Be genuinely informed in 5 minutes a day. No signup, no noise.
Get the free app, read the whole feed
InSnip turns the day's news into short, source-backed snippets with a plain why it matters line. The signal, not the scroll.